Opioid Peptides Suppress HIV Activation in Immune Cells by Over 40% | Research

The takeaway

Met-enkephalin, dynorphin, and kappa agonist U50,488 suppressed cytokine-induced HIV-1 expression by over 40% in chronically infected monocyte cells.

>40% HIV suppression
Multiple opioid peptides suppressed cytokine-triggered HIV-1 expression in chronically infected monocytes

What the researchers found

Met-enkephalin, dynorphin, and kappa agonist U50,488 suppressed IL-6-induced HIV-1 expression by over 40% in chronically infected monocyte cells.

Why it matters

Understanding how opioid peptides affect HIV is important because many HIV patients use opioid drugs for pain. This study suggests opioids might actually suppress viral activation in some immune cells.

How the study worked

U1 promonocyte cells chronically infected with HIV-1 were treated with opioid agonists with or without IL-6 stimulation. HIV-1 expression was measured by p24 antigen levels.

What this study cannot tell us

In vitro study using a single cell line. The U1 cell model does not represent all HIV-infected cell types. Effects in a living person with a complex immune system may differ greatly.

How to read the evidence

Preliminary — in vitro single cell line study. Cannot predict effects in living HIV patients with diverse infected cell types.

When this study was published

Published in 1995 (31 years ago). The opioid-HIV interaction remains relevant as opioid use is common among HIV patients.

The bigger picture

Many HIV patients need opioid pain medications. This study suggests opioids might actually suppress HIV reactivation in some immune cells — a potentially beneficial effect that complicates the usual assumption that opioids are immunosuppressive.

Questions still open

Do opioid drugs in HIV patients affect viral rebound?
Could kappa-selective opioids be developed as adjunct HIV therapy?

Common questions

Are opioids good or bad for HIV?

It's complicated. This study shows opioid peptides can suppress HIV activation in one type of immune cell. But other studies show opioids can suppress overall immune function. The net effect likely depends on which cells and which opioids are involved.

Does this mean HIV patients should take opioids?

No — this is an in vitro finding. But it suggests that for HIV patients who need opioid pain medications, the drugs might not be purely harmful to viral control, which is reassuring.

Read the original research

Endogenous opioid peptides suppress cytokine-mediated upregulation of HIV-1 expression in the chronically infected promonocyte clone U1.

Advances in experimental medicine and biology, 373, 65-72

View on PubMed ↗

Citation

Chao, C C; Gekker, G; Sheng, W S; Hu, S; Portoghese, P S; Peterson, P K. (1995). Endogenous opioid peptides suppress cytokine-mediated upregulation of HIV-1 expression in the chronically infected promonocyte clone U1.. Advances in experimental medicine and biology, 373, 65-72.